Ayuso GJL

Language: Spanish
References: 14
Page: 429-430
PDF size: 55.53 Kb.

Text Extraction

No abstract

REFERENCES

1. Agencia Española del Medicamento y Productos Sanitarios. Circular Nº3/2000. Disponible en httpwww.agemed.es.

2. Neutel C. The epidemiology of long-term benzodiazepine use. Int Rev Psychiatry 2005;17(3):189-97.

3. Rickels K et al. Controlled clinical trial of alprazolam for the treatment of anxiety. Am J Psychiatry 1983;140:82-85.

4. Pecknold JC et al. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. III. Discontinuation effects. Arch Gen Psychiatry 1988;45(5):429-36.

5. Kapczinski F et al. Antidepressants for generalized anxiety disorder.Cochrane Database Syst Rev. 20003;(2):CD003592.

6. Rickels K et al. Maintenance drug treatment for panic disorder. II.Short and long-term outcome after drug taper. Arch Gen Psychiatry 1993;50(1):61-8.

7. Rickels K et al. Paroxetine treatment of generalized anxiety disorder: A double-blind, placebo-controlled study. Am J Psychiatry 2003;160(4):749-57.

8. Gelenberg AJ et al. Efficacy of venlafaxine extended-release capsules in non depressed outpatients with generalized anxiety disorder. JAMA 2000;283(23):3082-8.

9. Wittchen HU et al. DSM-III-R Generalized anxiety disorder in the National Comorbidity Survey. Arch General Psychiatry 1994;51(5):519-23.

10. Roy-Byrne PP et al. Lifetime panic-depression comorbidity in the National Comorbidity Survey. Association with symptoms, course and helpseeking. Br J Psychiatry 2000;176:229-35.

11. Chignon JM et al. Panic disorder and alcoholism. Encephale 1991;17(6):519-23.

12. Katerndahl DA, Realini JP. Relationship between substance abuse and panic attacks. Addictive Behaviors 1999;24(5):731-6.

13. Stewart SA. The effects of benzodiazepines on cognition. J Clin Psychiatry 2005;66(supl. 2):9-13.

14. Baker MJ et al. An evaluation of persisting cognitive effects after withdrawal from long-term benzodiazepine use. J Int Neuropsychol Soc 2005;11(3):281-9.